Corcept Therapeutics (CORT) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $110.29 -3.98%
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.24, $0.01 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $87.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Lumentum shares rise on analyst upgrades, AI demand outlook
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
